Literature DB >> 35002469

Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states.

Edward Chau1, Jin Ryoun Kim1.   

Abstract

The aggregation of α-synuclein (αS) into oligomers and fibrils is implicated in the pathology of Parkinson's Disease (PD). While a molecular probe for rapid and comprehensive evaluation of αS aggregation states is critical for a better understanding of PD pathology, identification of therapeutic candidates, and the development of early diagnostic strategies, no such probe has yet to be developed. A structurally flexible αS variant, PG65, was previously developed as a target binding-driven, conformation-switching molecular probe for rapid αS oligomer detection. Though informative, detection using PG65 provides no comprehensive assessment of the αS aggregation states. In the present study, we report engineering of a molecular probe, PG65-MIMO (a PG65 variant with Multiple-Inputs and Multiple-Outputs), that rapidly (within 2 hr) produces comprehensive information on αS aggregation states. PG65-MIMO generates distinct fluorescence responses to the three major αS conformers (monomers, oligomers, and fibrils). PG65-MIMO also displays unique fluorescent signals for αS oligomers, depending on the tris(2-carboxyethyl)phosphine (TCEP) concentration. Our results suggest that the TCEP dependent signaling of PG65-MIMO may be associated with its conformational states. Overall, our study illustrates engineering of an αS variant to create a molecular probe for handling multiple inputs and multiple outputs, addressing the technological gap in αS detection.

Entities:  

Keywords:  Aggregation; Alpha-synuclein; Amyloid; Fibril; Oligomer; Protein probe

Year:  2021        PMID: 35002469      PMCID: PMC8740893          DOI: 10.1016/j.bej.2021.108292

Source DB:  PubMed          Journal:  Biochem Eng J        ISSN: 1369-703X            Impact factor:   3.978


  52 in total

1.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.

Authors:  María Soledad Celej; Rabia Sarroukh; Erik Goormaghtigh; Gerardo D Fidelio; Jean-Marie Ruysschaert; Vincent Raussens
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

Review 3.  Interrogating Amyloid Aggregates using Fluorescent Probes.

Authors:  Amir Aliyan; Nathan P Cook; Angel A Martí
Journal:  Chem Rev       Date:  2019-11-01       Impact factor: 60.622

Review 4.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Authors:  David J Irwin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2013-07-31       Impact factor: 34.870

5.  Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects.

Authors:  R Borghi; R Marchese; A Negro; L Marinelli; G Forloni; D Zaccheo; G Abbruzzese; M Tabaton
Journal:  Neurosci Lett       Date:  2000-06-16       Impact factor: 3.046

6.  Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway.

Authors:  Ji-Heui Seo; Jong-Cheol Rah; Se Hoon Choi; Jae Kyung Shin; Kyeoungsik Min; Hye-Sun Kim; Cheol Hyoung Park; Seonghan Kim; Eun-Mee Kim; Sang-Hyoung Lee; Sangho Lee; Se Won Suh; Yoo-Hun Suh
Journal:  FASEB J       Date:  2002-09-05       Impact factor: 5.191

7.  Dependence of alpha-synuclein aggregate morphology on solution conditions.

Authors:  Wolfgang Hoyer; Thomas Antony; Dmitry Cherny; Gudrun Heim; Thomas M Jovin; Vinod Subramaniam
Journal:  J Mol Biol       Date:  2002-09-13       Impact factor: 5.469

8.  Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.

Authors:  Marija Iljina; Gonzalo A Garcia; Mathew H Horrocks; Laura Tosatto; Minee L Choi; Kristina A Ganzinger; Andrey Y Abramov; Sonia Gandhi; Nicholas W Wood; Nunilo Cremades; Christopher M Dobson; Tuomas P J Knowles; David Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

9.  Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation.

Authors:  Serene W Chen; Srdja Drakulic; Emma Deas; Myriam Ouberai; Francesco A Aprile; Rocío Arranz; Samuel Ness; Cintia Roodveldt; Tim Guilliams; Erwin J De-Genst; David Klenerman; Nicholas W Wood; Tuomas P J Knowles; Carlos Alfonso; Germán Rivas; Andrey Y Abramov; José María Valpuesta; Christopher M Dobson; Nunilo Cremades
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-08       Impact factor: 11.205

10.  Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers.

Authors:  Rakez Kayed; Isabel Canto; Leonid Breydo; Suhail Rasool; Tamas Lukacsovich; Jessica Wu; Ricardo Albay; Anna Pensalfini; Stephen Yeung; Elizabeth Head; J Lawrence Marsh; Charles Glabe
Journal:  Mol Neurodegener       Date:  2010-12-13       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.